Sonoma pharmaceuticals and microsafe group announce that nanocyn® disinfectant & sanitizer has been approved by the australia tga with a 15 second sars-cov-2 (covid-19) kill time

Woodstock, ga.--(business wire)--sonoma pharmaceuticals, inc. (nasdaq: snoa), a global healthcare leader developing and producing stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound care, eye care, nasal care, oral care, dermatological conditions and disinfectant use, and its partner, the microsafe group, announce that the australian therapeutic goods administration (tga) has approved extended claims for nanocyn® disinfectant and sanitizer, which is ma
SNOA Ratings Summary
SNOA Quant Ranking